XML 15 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814
Collaborative Agreements (Details) - Collaborative Arrangement, Product [Member]
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 07, 2015
USD ($)
product
Nov. 14, 2014
Sep. 30, 2013
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2015
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Upfront payment received     $ 10,000    
INO-3112 [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Revenue recognized $ 15,000        
License To Research Collaboration Products [Member] | Nonsoftware License Arrangement [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Deferred revenue, additions 12,500        
INO 5150 [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Revenue recognized     5,000    
INO 1800 [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Revenue recognized     3,400    
Option Right [Member] | Nonsoftware License Arrangement [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Deferred revenue, additions     1,500    
Joint Steering Committee Obligation [Member] | Nonsoftware License Arrangement [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Deferred revenue, additions     155    
MedImmune [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Upfront payment received 27,500        
Anticipated development and regulatory event based payment receivable milestones $ 700,000        
Number of additional products to be developed | product 2        
Deferred revenue       $ 12,500 $ 12,500
Accounts receivable       140 140
Hoffman-La Roche [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Upfront payment received     10,000    
Anticipated development and regulatory event based payment receivable milestones     $ 3,000    
Length of period after date of product first commercial sale to determine agreement in effect terms     10 years    
Previously deferred revenue recognized       1,300 9,900
Revenue under collaborative research and development arrangements         3,000
Deferred revenue       313 313
Accounts receivable       $ 3,000 $ 3,000
Hoffman-La Roche [Member] | INO 5150 [Member]          
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]          
Days subsequent to termination notice effective   90 days